Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Nancy Paul Roc
ResearcherPublications, citations & collaboration network
Nancy Paul Roc is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 9 works, 24 citations, an h-index of 1 and an i10-index of 1.
9
Works
24
Citations
1
h-index
1
i10-index
IDs:OpenAlex
How has Nancy Paul Roc's publication output changed over time?
ScholarIQpublication output · 2022–2026
Output grew0% over the shown period — from 1 works in 2022 to 1 in 2026.
1
1
2
4
1
20222023202420252026
What are the most-cited papers on Nancy Paul Roc?
ScholarIQmost cited works
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison Wills, Dipti Tankala, Nancy Paul Roc, Stéphane Barakat
Journal of Medical Economics. 202323 CitationsOPEN ACCESS
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
Kimberly Guinan, Karine Mathurin, Jean Lachaîne, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Beenish S. Manzoor, Christopher Hillis, Versha Banerji
Cancers. 20241 CitationsOPEN ACCESS
The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab
Kimberly Guinan, Jean Lachaîne, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Christopher Hillis, Versha Banerji
Blood. 20220 Citations
Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada
Kimberly Guinan, Laurie Demers-Rozon, Monika Ham, Yoann Brassard, Nancy Paul Roc, Paola Lembo, Grace Christou, Christopher Lemieux, Stéphane Barakat, Yanqing Xu, Mathieu Pelletier, Jean Lachaîne
Blood. 20240 CitationsOPEN ACCESS
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Chakrapani Balijepalli, Lakshmi Gullapalli, Swati Prasad, Nancy Paul Roc, Ana Rusu, Natalia Price, W. J. Dempster, Stéphane Barakat
Journal of Comparative Effectiveness Research. 20250 CitationsOPEN ACCESS
Related on ScholarIQ
ABB (Canada)
Institution
Early access for innovative oncology medicines: a different story in each nation
Paper
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
Paper
The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab
Paper
Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada
Paper
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Paper